The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia.

[1]  K. Matsuo,et al.  Sex- and age-specific all-cause mortality in insomnia with hypnotics: Findings from Japan multi-institutional Collaborative Cohort Study. , 2022, Sleep medicine.

[2]  Shangjia Dong,et al.  Gender differences in the prevalence of and trends in sleep patterns and prescription medications for insomnia among US adults, 2005 to 2018. , 2022, Sleep health.

[3]  K. Murray,et al.  Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study , 2021, PLoS medicine.

[4]  Sarah M. Hartz,et al.  Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015 , 2020, JAMA network open.

[5]  E. Bixler,et al.  Effects of trazodone versus cognitive behavioral therapy in the insomnia with short sleep duration phenotype: a preliminary study. , 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[6]  T. Åkerstedt,et al.  Short‐ and long‐term mortality following hypnotic use , 2020, Journal of sleep research.

[7]  G. Guyatt,et al.  Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies. , 2019, Sleep medicine reviews.

[8]  A. Krystal,et al.  The assessment and management of insomnia: an update , 2019, World psychiatry : official journal of the World Psychiatric Association.

[9]  Simon B. Goldberg,et al.  New Coprescription of Opioids and Benzodiazepines and Mortality Among Veteran Affairs Patients With Posttraumatic Stress Disorder. , 2019, The Journal of clinical psychiatry.

[10]  T. Iwashyna,et al.  Using Veterans Affairs Corporate Data Warehouse to identify 30-day hospital readmissions , 2018, Health Services and Outcomes Research Methodology.

[11]  J. Schinka,et al.  Mortality and Cause of Death in Younger Homeless Veterans , 2018, Public health reports.

[12]  Norio Watanabe,et al.  Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. , 2017, Sleep medicine reviews.

[13]  Harvey Goldstein,et al.  Challenges in administrative data linkage for research , 2017, Big Data Soc..

[14]  A. Öjehagen,et al.  Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study. , 2017, Drug and alcohol dependence.

[15]  H. Cai,et al.  Sleep duration and risk of all-cause mortality: A flexible, non-linear, meta-regression of 40 prospective cohort studies. , 2017, Sleep medicine reviews.

[16]  D. Hemavathy,et al.  Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities , 2016, Journal of family medicine and primary care.

[17]  D. Kansagara,et al.  Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. , 2016, Annals of internal medicine.

[18]  J. Hébert,et al.  The National Veteran Sleep Disorder Study: Descriptive Epidemiology and Secular Trends, 2000-2010. , 2016, Sleep.

[19]  Richard Olmstead,et al.  Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation , 2016, Biological Psychiatry.

[20]  A. Parsaik,et al.  Mortality associated with anxiolytic and hypnotic drugs—A systematic review and meta-analysis , 2016, The Australian and New Zealand journal of psychiatry.

[21]  D. Kripke.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit , 2016, F1000Research.

[22]  T. Lallukka,et al.  Insomnia symptoms and mortality: a register‐linked study among women and men from Finland, Norway and Lithuania , 2016, Journal of sleep research.

[23]  B. Edwards,et al.  Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold. , 2015, Annals of the American Thoracic Society.

[24]  R. Bootzin,et al.  Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: Pilot results from a randomized controlled comparative efficacy trial , 2015, Psychoneuroendocrinology.

[25]  Richard Olmstead,et al.  Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. , 2014, Sleep.

[26]  Atul Malhotra,et al.  Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold. , 2014, Sleep.

[27]  F. Hu,et al.  Association Between Insomnia Symptoms and Mortality: A Prospective Study of US Men , 2014, Circulation.

[28]  Julio Fernandez-Mendoza,et al.  Insomnia and its Impact on Physical and Mental Health , 2013, Current Psychiatry Reports.

[29]  K. Pérès,et al.  Hypnotics and mortality in an elderly general population: a 12-year prospective study , 2013, BMC Medicine.

[30]  D. Kripke,et al.  Hypnotics' association with mortality or cancer: a matched cohort study , 2012, BMJ Open.

[31]  I. Janszky,et al.  Insomnia and the Risk of Acute Myocardial Infarction: A Population Study , 2011, Circulation.

[32]  D. Hudgel,et al.  Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. , 2011, Sleep.

[33]  J. Difede,et al.  The nature and course of subthreshold PTSD. , 2010, Journal of anxiety disorders.

[34]  C. Vogeli,et al.  Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions , 2010, Journal of General Internal Medicine.

[35]  J. Montplaisir,et al.  Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. , 2009, Sleep.

[36]  Anders Engeland,et al.  Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. , 2008, Sleep medicine.

[37]  Daniel J. Taylor,et al.  Comorbidity of chronic insomnia with medical problems. , 2007, Sleep.

[38]  Michal Abrahamowicz,et al.  Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. , 2005, American journal of epidemiology.

[39]  D. Mannino,et al.  Does insomnia kill? , 2005, Sleep.

[40]  N. Breslau,et al.  Partial PTSD versus full PTSD: an empirical examination of associated impairment , 2004, Psychological Medicine.

[41]  Sebastian Schneeweiss,et al.  Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. , 2004, American heart journal.

[42]  W. Longstreth,et al.  Validating Administrative Data in Stroke Research , 2002, Stroke.

[43]  D. Kripke,et al.  Mortality associated with sleep duration and insomnia. , 2002, Archives of general psychiatry.

[44]  G. Berglund,et al.  Sleep disturbance in association with elevated pulse rate for prediction of mortality – consequences of mental strain? , 2001, Journal of internal medicine.

[45]  E. Bixler,et al.  Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. , 2001, The Journal of clinical endocrinology and metabolism.

[46]  Y Ohno,et al.  Sleep patterns and total mortality: a 12-year follow-up study in Japan. , 2000, Journal of epidemiology.

[47]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[48]  K. Morgan.  Hypnotics, Sleep, and Mortality in Elderly People , 1992, Journal of the American Geriatrics Society.

[49]  L. Breiman.  Random Forests , 2001, Machine Learning.

[50]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.